Drugs / A-831
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00522808 | Aug 2007 → Mar 2008 | chronic hepatitis C virus infection | Arrow Therapeutics | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A-831 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00522808 ↗ |
| Route | Oral | “Multiple Oral Doses of A-831” NCT00522808 ↗ |